Antihypertensive drugs in COVID-19 infection

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European heart journal. Cardiovascular pharmacotherapy 2020-11, Vol.6 (6), p.415-416
Hauptverfasser:	Pinto-Sietsma, Sara-Joan, Flossdorf, Michael, Buchholz, Veit R, Offerhaus, Joost, Bleijendaal, Hidde, Beudel, Martijn, Volders, Paul G A, ter Bekke, Rachel M A, Dormans, Tom, Zwetsloot, Peter-Paul, de Jager, Peter, Massberg, Steffen, Rämer, Patrick, Wendtner, Clemens, Hoffmann, Ellen, Rothe, Kathrin, Feihl, Susanne, Kessler, Thorsten, Pinto, Yigal M, Schunkert, Heribert
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenergic beta-Antagonists - administration & dosage Angiotensin Receptor Antagonists - administration & dosage Angiotensin-Converting Enzyme Inhibitors - administration & dosage Antihypertensive Agents - administration & dosage Antihypertensive Agents - adverse effects Antihypertensive drugs Calcium Channel Blockers - administration & dosage Coronavirus Infections - diagnosis Coronavirus Infections - mortality Coronavirus Infections - therapy Correspondence COVID-19 Diuretics - administration & dosage Drug Administration Schedule Enzyme inhibitors Germany Health aspects Hospitalization Humans Hypertension Hypertension - diagnosis Hypertension - drug therapy Hypertension - mortality Infection Medical research Medicine, Experimental Netherlands Pandemics Pneumonia, Viral - diagnosis Pneumonia, Viral - mortality Pneumonia, Viral - therapy Protective Factors Risk Factors Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:
ISSN:	2055-6837 2055-6845
DOI:	10.1093/ehjcvp/pvaa058